RP903

· Risen (Suzhou) Pharma Tech Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RP903, covering 2025-12-23 to 2025-12-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Indications of RP903 [Phase 1]